- Glooko publishes a data management platform for people with diabetes.
- Today, the company claims 1 million patients.
- The company has, in total, raised $ 71 million since its inception.
Glooko, a data management platform for people with diabetes, announces a new funding round of $ 35 million, led by Georgian Partners, Insulet Corporation and Mayo Clinic. The company has already completed six fundraisers for a total amount, including the last, of $ 71 million.
Created in November 2010 by Yogen Dalal, Chamath Palihapitiya and Sundeep Madra, Glooko publishes a platform that lists all the data of patients with diabetes. Intended for physicians, the information collected, listed and analyzed will ultimately allow patients to better manage their diabetes. The start-up claims 1 million users.
The company recently partnered with Dexcom, an app that lets patients know their blood sugar levels. On the competition side, the start-up must in particular face Medtronic with its Guardian Connect tool, a portable continuous glucose measurement system.
With this new investment, Glooko wishes to strengthen its sales, marketing and development teams. This round of funding will also allow it to develop in France, Germany, Asia and the Middle East. “This additional funding will help us continue our mission of improving the lives of people with diabetes,” said Rick Altinger, CEO of Glooko.
Founders: Yogen Dalal, Chamath Palihapitiya and Sundeep Madra
Creation date : 2010
Seat : United States
Activity: diabetic data management platform
Competitors: Medtronic …